Complete sequence of a novel protein containing a femtomolar-activity- dependent neuroprotective peptide

Journal of Neurochemistry

Volumn 72, Issue 3, 1999, Pages 1283-1293

  Bassan, Merav ^a   Zamostiano, Rachel ^a   Davidson, Ariane ^a   Pinhasov, Albert ^a   Giladi, Eliezer ^a   Perl, Orly ^a   Bassan, Haim ^a   Blat, Cila ^a   Gibney, Gretchen ^b   Glazner, Gordon ^b   Brenneman, Douglas E ^b   Gozes, Illana ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Apolipoprotein E; Learning and memory; Molecular cloning; mRNA; Neuronal survival; Vasoactive intestinal peptide

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; GLYCOPROTEIN GP 120; N METHYL DEXTRO ASPARTIC ACID; NEUROTROPHIC FACTOR; TETRODOTOXIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ASTROCYTE; CEREBELLUM; GENE EXPRESSION; GLIA CELL; HIPPOCAMPUS; LEARNING; MEMORY; MOLECULAR CLONING; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT; SHORT TERM MEMORY;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEINS E; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CLONING, MOLECULAR; HOMEODOMAIN PROTEINS; HUMANS; MAZE LEARNING; MEMORY; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDES; RATS; RNA, MESSENGER;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033049956     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721283.x     Document Type: Article

References (60)

1. Barbu V. and Dautry F. (1989) Northern blot normalization with a 28S rRNA oligodeoxynucleotide probe. Nucleic Acids Res. 17, 7115.
2. Bassan M., Zamostiano R., Giladi E., Davidson A., Wollman Y., Pitman J., Hauser J., Brenneman D. E., and Gozes I. (1998) The identification of secreted heat shock 60-like protein from rat glial cells and a human neuroblastoma cell line. Neurosci. Lett. 249, 1-4.
3. Bockova J., Elias D., and Cohen I. R. (1997) Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J. Autoimmun. 10, 323-329.
4. Brenneman D. E. and Eiden L. E. (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA 83, 1159-1162.
5. Brenneman D. E. and Gozes I. (1996) A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97, 2299-2307.
6. Brenneman D. E., Neale E. A., Foster G. A., D'autremont S. W., and Westbrook G. L. (1987) Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J. Cell Biol. 104, 1603-1610.
7. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., and Pert C. B. (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335, 639-642.
8. Brenneman D. E., Nicol T., Warren D., and Bowers L. M. (1990) Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25, 386-394.
9. Brenneman D. E., Schultzberg M., Bartfai T., and Gozes I. (1992) Cytokine regulation of neuronal survival. J. Neurochem. 58, 454-460.
10. Brenneman D. E., Hill J. M., Glazner G. W., Gozes I., and Phillips T. W. (1995) Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci. 13, 187-210.
11. Brenneman D. E., Hauser J., Neale E. A., Rubinraut S., Fridkin A., Davidson A., and Gozes I. (1998a) Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J Pharmacol. Exp. Ther. 285, 619-627.
12. Brenneman D. E., Hill J. M., Gressens P., and Gozes I. (1998b) Neurotrophic action of VIP: from CNS ontogeny to therapeutic strategy, in Proinflammatory and Antiinflammatory Peptides (Said S. I., ed), pp. 383-408. Marcel Dekker, New York.
13. Cafe C., Tori C., Bertorelli L., Angeretti N., Lucca E., Forloni G., and Marzatico F. (1996) Oxidative stress after acute and chronic application of beta-amyloid fragment 25-35 in cortical cultures. Neurosci. Lett. 203, 61-65.
14. Chang C., Saltzman A. G., Hiipakka R. A., Huang I.-Y., and Liao S. (1987) Prostatic spermine-binding protein. Cloning and nucleotide sequence of cDNA, amino acid sequence, and androgenic control of mRNA level. J. Biol. Chem. 262, 11901-11903.
15. Chapman S. and Michaelson D. M. (1998) Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice. J. Neurochem. 70, 708-714.
16. Chestukhin A., Litovchick L., Muradov K., Batkin M., and Shaltiel S. (1997) Unveiling the substrate specificity of meprin β on the basis of the site in protein kinase A cleaved by the kinase splitting membranal proteinase. J. Biol. Chem. 272, 3153-3160.
17. Chou P. Y. and Fasman G. D. (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 47, 45-148.
18. Clos J. and Dicou E. (1997) Two peptides derived from the nerve growth factor precursor enhance cholinergic enzyme activities in vivo. Dev. Brain Res. 99, 267-270.
19. Dicou E., Pflug B., Magazin M., Lehy T., Djakiew D., Ferrara P., Nerriere V., and Harvie D. (1997) Two peptides derived from the nerve growth factor precursor are biologically active. J. Cell Biol. 136, 389-398.
20. Festoff B. W., Nelson J. B., and Brenneman D. E. (1996) Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin-1. J. Neurobiol. 30, 255-266.
21. 1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice. J. Neurochem. 70, 1991-1997.
22. Fonnum F. (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24, 407-409.
23. Glazer R. and Gozes I. (1994) Diurnal oscillation in vasoactive intestinal peptide gene expression independent of environmental light entraining. Brain Res. 644, 164-168.
24. Glazner G. W., Brenneman D. E., Gozes I., and Mattson M. P. (1997) A 9 amino acid peptide fragment of activity-dependent neurotrophic factor (ADNF) protects neurons from oxidative stress-induced death. Soc. Neurosci. Abstr. 23, 2249.
25. Gordon I., Grauer E., Genis I., Sehayek E., and Michaelson D. M. (1995) Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199, 1-4.
26. Gozes I. and Brenneman D. E. (1993) Neuropeptides as growth and differentiation factors in general and VIP in particular. J. Mol. Neurosci. 4, 1-9.
27. Gozes I. and Brenneman D. E. (1996) Activity-dependent neurotrophic factor (ADNF): an extracellular neuroprotective chaperonin? J. Mol. Neurosci. 7, 235-244.
28. Gozes I., Shani Y., and Rostene W. H. (1987) Developmental expression of the VIP-gene in brain and intestine. Mol. Brain Res. 2, 137-148.
29. Gozes I., McCune S. K., Jacobson L., Warren D., Moody T. W., Fridkin M., and Brenneman D. E. (1991) An antagonist to vaso-active intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257, 959-966.
30. Gozes I., Bardea A., Reshef A., Zamostiano R., Zhukovsky S., Rubinraut S., Fridkin M., and Brenneman D. E. (1996) Novel neuro-protective strategy for Alzheimer's disease: inhalation of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA 93, 427-432.
31. Gozes I., Davidson A., Gozes Y., Mascolo R., Barth R., Warren D., Hauser J., and Brenneman D. E. (1997a) Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity. Dev. Brain Res. 99, 167-175.
32. Gozes I., Bachar M., Bardea A., Davidson A., Rubinraut S., Fridkin M., and Giladi E. (1997b) Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implication for early treatment of Alzheimer's disease. J. Neurobiol. 33, 329-342.
33. Hamburger V. and Levi-Montalcini R. (1949) Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J. Exp. Zool. 11, 457-468.
34. Johnson G. P., Goebel S. J., Perkus M. E., Davis S. W., Winslow J. P., and Paoletti E. (1991) Vaccinia virus encodes a protein with similarity to glutaredoxins. Virology 181, 378-381.
35. Lipton S. A., Sucher N. J., Kaiser P. K., and Dreyer E. B. (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7, 111-118.
36. Ma J., Yee A., Brewer H. B. Jr., Das S., and Potter H. (1994) Amyloid-associated protein alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372, 92-94.
37. Ma J., Brewer H. B., and Potter H. (1996) Alzheimer A beta neuro-toxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides. Neurobiol. Aging 17, 773-780.
38. Maness L. M., Kastin A. J., Weber J. T., Banks W. A., Beckman B. S., and Zadina J. E. (1994) The neurotrophins and their receptors: structure, function, and neuropathology. Neurosci. Biobehav. Rev. 18, 143-159.
39. Mark R. J., Blanc E. M., and Mattson M. P. (1996) Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol. Neurobiol. 12, 211-224.
40. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
41. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., and Roses A. (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136, 107-122.
42. Masliah E., Samuel W., Veinbergs I., Mallory M., Mante M., and Saitoh T. (1997) Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751, 307-314.
43. McDonald M. P. and Crawley J. N. (1997) Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease. J. Psychiatry Neurosci. 22, 303-317.
44. Morris R. (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 11, 47-60.
45. Oitzl M. S., Mulder M., Lucassen P. J., Havekes L. M., Grootendorst J., and de Kloet E. R. (1997) Severe learning deficits in apolipoprotein E knockout mice in a water maze task. Brain Res. 752, 189-196.
46. Paradis E., Douillard H., Koutroumanis M., Goodyer C., and Leblanc I. (1996) Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. Neurosci. 16, 7533-7539.
47. Patterson P. H. (1992) The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL6; next ONC, MGF, GCSF? Curr. Opin. Neurobiol. 2, 94-97.
48. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., and Breslow J. L. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353.
49. Prehn J. H., Bindokas V. P., Jordan J., Galindo M. F., Ghadge G. D., Roos R. P., Boise L. H., Thompson C. B., Krajewski S., Reed J. C., and Miller R. J. (1996) Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49, 319-328.
50. Rappoport D. A. and Fritz R. R. (1972) Molecular biology of the developing mammalian brain, in The Structure and Function of the Nervous Tissue, Vol. VI (Bourne G. H., ed), pp. 273-316. Academic Press, New York.
51. Rosenfeld R. and Margalit H. (1993) Zinc fingers: conserved properties that can distinguish between spurious and actual DNA-binding motifs. J. Biomol. Struct. Dyn. 11, 557-570.
52. Said S. I. (1996) Molecules that protect: the defense of neurons and other cells. J. Clin. Invest. 97, 2163-2164.
53. Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning: A Laborotory Manual, 2nd edit. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
54. Schapira A. H. (1996) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr. Opin. Neurol. 9, 260-264.
55. Schmechel D., Marangos P. J., Zis A. P., Brightman M., and Goodwin F. K. (1978) Brain endolases as specific markers of neuronal and glial cells. Science 199, 313-315.
56. Schwanz J. P. (1998) Development and plasticity. Overview. Adv. Pharmacol. 42, 877-882.
57. Selkoe D. J. (1993) Physiological production of the beta amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16, 403-409.
58. Taira M., Hayes W. P., Otani H., and Dawid I. B. (1993) Expression of LIM class homeobox gene Xlim-3 in Xenopus development is limited to neural and neuroendocrine tissues. Dev. Biol. 159, 245-256.
59. Weisgraber K. H., Pitas R. E., and Mahley R. W. (1994) Lipoproteins, neurobiology and Alzheimer's disease: structure and function of apolipoprotein E. Curr. Opin. Struct. Biol. 4, 507-515.
60. Zhao D.. McCaffery P., Ivins K. J., Neve R. L., Hogan P., Chin W. W., and Drager U. C. (1996) Molecular identification of a major retinoic-acid-synthesizing enzyme, a retinaldehyde-specific dehydrogenase. Eur. J. Biochem. 240, 15-22.